Mid-Cap
Macy’s Beats Earnings Expectations but Slashes Full-Year Sales Forecast Amid Selective Consumer Spending
Despite Positive Earnings, the Department Store Giant Struggles with Declining Sales and a Challenging Retail Environment Macy’s (M), one of...
Rivian Temporarily Halts Production of Amazon’s Electric Delivery Vans Amid Ongoing Supply Chain Struggles
The EV Maker Faces New Setbacks Due to Parts Shortages, But Remains Optimistic About Meeting Production Targets Rivian Automotive (RIVN),...
Robinhood: Seizing Opportunity Amid Market Pullback and Strategic Innovation
Upgraded to Overweight as New Products and Generational Shifts Poise Robinhood for Long-Term Growth Robinhood Markets (HOOD), the pioneering mobile-first...
Paramount Global’s Stock Surges as Streaming Division Hits Profit Amid Significant Layoffs and Challenges
Despite Headwinds in Legacy Media, Paramount Eyes Future Growth with Strategic Restructuring and a Pending Merger with Skydance Media Paramount...
Rivian’s Bumpy Road Ahead: Mixed Q2 Results, Production Woes, and a Glimmer of Hope with Volkswagen Partnership
Q2 Financial Performance: A Mixed Bag Rivian Automotive (RIVN) faced a significant setback in premarket trading on Wednesday, with its...
Enovix Corporation Reports Robust Growth and Strategic Advancements in Q2 2024
Expansion in Malaysia, New Collaborations, and Financial Performance Highlight the Quarter Enovix Corporation (ENVX), a global leader in high-performance battery...
Corbus Pharmaceuticals: Pioneering Next-Generation Therapies in Cancer and Obesity
Revolutionary Treatments on the Horizon with CRB-701 and CRB-913 Corbus Pharmaceutical (CRPB), an early-stage clinical biotechnology company, is making significant...
TARS Pharmaceuticals: XDEMVY Eye Drops Set for Strong Performance in 2Q24 Amid Strategic Sales Expansion
Anticipated Growth in XDEMVY Sales, Sales Force Expansion, and Promising Pipeline Signal a Bright Future for TARS Pharmaceuticals As we...
Viking Therapeutics Advances Multiple Therapies Amid Strong Clinical Progress and Financial Stability
Obesity Drug VK2735 to Enter Phase 3, NASH Therapy VK2809 Shows Promising Results, and Novel Treatments in Development Viking Therapeutics...
Cleveland-Cliffs Reports Strong Q2 Results Amid Strategic Moves and Market Dynamics
Financial Performance and Strategic Investments Shape a Promising Future Cleveland-Cliffs (CLF) has announced its second-quarter results for the period ending...
